Enanta Pharmaceuticals (ENTA) Free Cash Flow Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) Free Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Enanta Pharmaceuticals |
319.55 Mn |
155.77 Mn |
- |
55.25% |
| Date | Value |
|---|
| Mar 31, 2026 |
55.25% |
| Dec 31, 2025 |
53.64% |
| Sep 30, 2025 |
17.98% |
| Jun 30, 2025 |
246.21% |
| Mar 31, 2025 |
47.05% |
| Dec 31, 2024 |
0.89% |
| Sep 30, 2024 |
4.52% |
| Jun 30, 2024 |
45.34% |
| Mar 31, 2024 |
-87.24% |
| Dec 31, 2023 |
33.56% |
| Sep 30, 2023 |
-43.02% |
| Jun 30, 2023 |
-14.83% |
| Mar 31, 2023 |
39.60% |
| Dec 31, 2022 |
-191.33% |
| Sep 30, 2022 |
26.17% |
| Jun 30, 2022 |
-2.22% |
| Mar 31, 2022 |
-468.40% |
| Dec 31, 2021 |
11.68% |
| Sep 30, 2021 |
-41.73% |
| Jun 30, 2021 |
-524.28% |
